Mirum Pharmaceuticals reported a gross margin of 82.78% and a net margin of -38.14% for the quarter ended Jun 2026. These financial ratios cover 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||
| Gross Margin | 100.00% | 39.36% | 81.20% | 85.56% | 84.39% | 83.90% | 84.24% | 81.83% | 78.57% | 64.03% | 74.24% | 74.03% | 76.98% | 77.09% | 79.37% | 81.67% | 80.80% | 81.02% | 81.98% | 82.78% | ||||||||
| EBT Margin | -941.98% | 1,825.75% | -283.86% | -191.56% | -190.06% | -130.05% | -94.72% | -196.61% | -48.90% | -50.94% | -35.62% | -30.82% | -15.37% | -24.51% | -12.23% | -4.27% | 1.99% | -3.33% | -493.91% | -37.19% | ||||||||
| EBIT Margin | -856.48% | -1,452.36% | -253.92% | -179.83% | -175.09% | -122.41% | -85.92% | -64.73% | -52.69% | -46.85% | -38.24% | -31.12% | -14.03% | -24.36% | -13.61% | -3.90% | 1.96% | -3.07% | -493.78% | -24.14% | ||||||||
| EBITDA Margin | -856.48% | -1,452.36% | -253.92% | -179.83% | -175.09% | -122.41% | -85.92% | -64.73% | -52.69% | -46.85% | -38.24% | -31.12% | -14.03% | -24.36% | -13.61% | -3.90% | 1.96% | -3.07% | -493.78% | -24.14% | ||||||||
| Operating Margin | -856.48% | -1,452.36% | -253.92% | -179.83% | -175.09% | -122.41% | -85.92% | -64.73% | -52.69% | -46.85% | -38.24% | -31.12% | -14.03% | -24.36% | -13.61% | -3.90% | 1.96% | -3.07% | -493.78% | -24.14% | ||||||||
| Net Margin | -942.16% | 1,825.37% | -283.94% | -153.98% | -190.13% | -130.55% | -95.35% | -197.45% | -49.42% | -51.27% | -36.52% | -31.64% | -15.75% | -23.93% | -13.15% | -4.59% | 2.18% | -3.85% | -494.21% | -38.14% | ||||||||
| FCF Margin | -684.40% | -1,056.41% | -307.70% | -115.47% | -138.68% | -123.67% | -59.54% | -46.40% | -38.18% | -23.89% | 21.96% | -5.88% | 4.21% | -5.12% | -1.79% | 9.32% | 29.69% | 3.67% | -143.50% | -25.12% | ||||||||
| Efficiency | ||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 1.55M | 3.05M | 5.73M | 6.25M | 6.09M | 7.56M | 15.38M | 22.28M | 21.96M | 21.02M | 21.02M | 22.00M | 22.41M | 22.68M | 23.48M | 24.45M | 25.20M | 25.64M | ||||||||||
| Assets AverageAssets Avg. | 241.42M | 264.91M | 286.40M | 287.69M | 330.79M | 358.63M | 343.22M | 388.56M | 547.12M | 648.63M | 649.29M | 656.36M | 664.32M | 669.32M | 680.50M | 708.03M | 755.47M | 813.96M | 866.86M | 967.95M | ||||||||
| Invested CapitalInvested Cap. | 57.24M | 122.21M | 110.93M | 112.45M | 171.06M | 143.13M | 142.24M | 78.61M | 269.08M | 248.67M | ||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.07 | 0.07 | 0.11 | 0.13 | 0.16 | 0.21 | 0.28 | 0.30 | 0.26 | 0.29 | 0.34 | 0.40 | 0.46 | 0.50 | 0.56 | 0.61 | 0.62 | 0.64 | 0.66 | 0.64 | ||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | -7.56 | -12.10 | -8.67 | -8.11 | -8.28 | -7.84 | -6.40 | -6.51 | -7.04 | -9.15 | -7.40 | -6.79 | -3.54 | -6.77 | -4.22 | -1.39 | 0.72 | -1.27 | -218.33 | -16.25 | ||||||||
| Debt Ratio | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | |||||||||||||||||||||
| Times Interest Earned | -7.56 | -12.10 | -8.67 | -8.11 | -8.28 | -7.84 | -6.40 | -6.51 | -7.04 | -9.15 | -7.40 | -6.79 | -3.54 | -6.77 | -4.22 | -1.39 | 0.72 | -1.27 | -218.33 | -16.25 | ||||||||
| Valuation | ||||||||||||||||||||||||||||
| Price to EarningsP/E | -12.86 | 8.52 | -19.08 | -23.63 | -21.66 | -19.78 | -30.30 | -13.36 | -62.42 | -38.68 | -46.77 | -66.02 | -131.42 | -84.02 | -151.79 | -434.65 | 0.00M | -715.41 | -7.12 | -112.76 | ||||||||
| Price to SalesP/S | 121.14 | 155.45 | 54.17 | 36.38 | 41.19 | 25.82 | 28.90 | 26.37 | 30.85 | 19.83 | 17.08 | 20.89 | 20.70 | 20.11 | 19.96 | 19.94 | 28.28 | 27.52 | 35.20 | 43.01 | ||||||||
| Price to BookP/B | 10.74 | 4.06 | 6.41 | 5.75 | 4.57 | 5.07 | 6.47 | 12.58 | 5.47 | 5.55 | 5.04 | 7.10 | 8.06 | 8.86 | 9.55 | 9.98 | 12.88 | 13.03 | 23.21 | -727.39 | ||||||||
| Enterprise Value | 266.50M | 231.25M | 364.78M | 341.45M | 338.57M | 468.93M | 780.98M | 658.85M | 1,166.40M | 1,092.94M | 879.33M | 1,348.11M | 1,586.31M | 1,718.04M | 1,950.10M | 2,242.92M | 3,386.29M | 3,715.97M | 5,242.10M | 7,142.54M | ||||||||
| EV to EBIT | -6.22 | -5.07 | -11.14 | -10.86 | -10.30 | -13.73 | -28.77 | -27.14 | -46.38 | -33.54 | -33.22 | -55.63 | -125.06 | -70.93 | -128.44 | -449.57 | 0.00M | -813.66 | -6.64 | -167.91 | ||||||||
| EV to EBITDA | -6.22 | -5.07 | -11.14 | -10.86 | -10.30 | -13.73 | -28.77 | -27.14 | -46.38 | -33.54 | -33.22 | -55.63 | -125.06 | -70.93 | -128.44 | -449.57 | 0.00M | -813.66 | -6.64 | -167.91 | ||||||||
| Market Capitalization | 605.69M | 487.79M | 698.32M | 636.13M | 773.46M | 720.65M | 913.05M | 988.80M | 1,472.43M | 1,379.27M | 1,182.18M | 1,626.48M | 1,870.76M | 1,998.78M | 2,227.78M | 2,547.47M | 3,761.84M | 4,099.30M | 5,628.36M | 7,580.83M | ||||||||
| Price to FCFP/FCF | -17.70 | -14.71 | -17.60 | -31.51 | -29.70 | -20.88 | -48.53 | -56.83 | -80.81 | -83.00 | 77.78 | -354.97 | 491.92 | -392.84 | -0.00M | 213.82 | 95.25 | 749.83 | -24.53 | -171.22 | ||||||||
| EV to FCF | -7.79 | -6.98 | -9.20 | -16.91 | -13.00 | -13.59 | -41.51 | -37.87 | -64.01 | -65.77 | 57.85 | -294.22 | 417.12 | -337.67 | -974.08 | 188.26 | 85.74 | 679.71 | -22.85 | -161.32 | ||||||||
| EV to CFO | -7.79 | -6.98 | -9.20 | -16.93 | -13.01 | -13.68 | -41.60 | -38.02 | -64.01 | -65.77 | 57.81 | -354.49 | 398.17 | -339.00 | -994.44 | 186.29 | 85.34 | 612.49 | -22.91 | -161.41 | ||||||||
| Return Ratios | ||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -856.48% | -1,452.36% | -253.92% | -179.83% | -175.09% | -122.41% | -85.92% | -64.73% | -52.69% | -46.85% | -38.24% | -31.12% | -14.03% | -24.36% | -13.61% | -3.90% | 1.96% | -3.07% | -493.78% | -24.14% | ||||||||
| Return on Capital Employed [ROCE]ROCE | -86.26% | -78.00% | -62.95% | -62.91% | -51.05% | -44.65% | -42.68% | -35.86% | -23.44% | -19.44% | -19.96% | -19.93% | -17.49% | -16.14% | -13.80% | -10.13% | -7.02% | -3.64% | -134.07% | -111.92% | ||||||||
| Return on Invested Capital [ROIC]ROIC | -212.41% | -193.36% | -136.09% | -121.70% | -87.06% | -79.76% | -84.01% | -107.69% | -64.05% | -42.42% | ||||||||||||||||||
| Return on Assets [ROA]ROA | -74.08% | -31.80% | -24.56% | -18.55% | -12.68% | -37.83% | -37.64% | -45.37% | -30.01% | -25.19% | -24.42% | -16.63% | -15.02% | -13.14% | -11.37% | -8.27% | -5.48% | -2.87% | -92.15% | -88.87% |